Doctors develop new treatment for cystic fibrosisBMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7237.736/c (Published 18 March 2000) Cite this as: BMJ 2000;320:736
- Judy Siegel-Itzkovich
Antibiotic nose drops given to Israeli children and adults born with cystic fibrosis have reversed the effects of a defective gene that causes the disease in 60% of Ashkenazi (European) Jews who have cystic fibrosis and 5% of all cases worldwide.
The results of a two week pilot study, conducted on nine patients aged 12 to 42 by two researchers at Jerusalem's Shaare Zedek Medical Centre, have been called a “significant breakthrough” in the search for a cure for a type of cystic fibrosis to which …
Log in using your username and password
Log in through your institution
Sign up for a free trial